Morepen Laboratories Limited

NSEI:MOREPENLAB 주식 보고서

시가총액: ₹40.6b

Morepen Laboratories 관리

관리 기준 확인 3/4

Morepen Laboratories CEO는 Sushil Suri, Oct2000 에 임명되었습니다 의 임기는 24.08 년입니다. 는 ₹ 496.16M 가치에 해당하는 회사 주식의 1.22% 직접 소유합니다. 496.16M. 경영진과 이사회의 평균 재임 기간은 각각 7.9 년과 4.8 년입니다.

주요 정보

Sushil Suri

최고 경영자

₹39.1m

총 보상

CEO 급여 비율n/a
CEO 임기24.1yrs
CEO 소유권1.2%
경영진 평균 재임 기간7.9yrs
이사회 평균 재임 기간4.8yrs

최근 관리 업데이트

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Recent updates

There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump

Aug 20
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump

Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)

Aug 09
Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)

Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified

Jul 05
Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified

Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?

Jun 13
Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?

Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing

Apr 23
Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing

Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly

Nov 23
Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Aug 10
Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 21
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Apr 05
Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?

Sep 14
Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?

Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

May 21
Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?

Mar 12
Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?

Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay

Feb 22
Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay

Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 07
Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain

Jan 21
Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain

Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet

Jan 03
Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet

Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?

Dec 16
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?

Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Nov 28
Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

CEO 보상 분석

Sushil Suri 의 보수는 Morepen Laboratories 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024₹39mn/a

₹962m

Dec 31 2023n/an/a

₹761m

Sep 30 2023n/an/a

₹531m

Jun 30 2023n/an/a

₹477m

Mar 31 2023₹48m₹44m

₹387m

Dec 31 2022n/an/a

₹428m

Sep 30 2022n/an/a

₹553m

Jun 30 2022n/an/a

₹768m

Mar 31 2022₹91m₹87m

₹1b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹1b

Jun 30 2021n/an/a

₹1b

Mar 31 2021₹54m₹51m

₹971m

Dec 31 2020n/an/a

₹814m

Sep 30 2020n/an/a

₹684m

Jun 30 2020n/an/a

₹453m

Mar 31 2020₹17m₹16m

₹336m

Dec 31 2019n/an/a

₹331m

Sep 30 2019n/an/a

₹312m

Jun 30 2019n/an/a

₹340m

Mar 31 2019₹12m₹11m

₹288m

Dec 31 2018n/an/a

₹252m

Sep 30 2018n/an/a

₹267m

Jun 30 2018n/an/a

₹308m

Mar 31 2018₹6m₹4m

₹296m

보상 대 시장: Sushil 의 총 보상 ($USD 464.10K )은 Indian 시장( $USD 271.25K ).

보상과 수익: Sushil 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Sushil Suri (60 yo)

24.1yrs

테뉴어

₹39,112,000

보상

Mr. Sushil Suri, B.Sc., FCA has been Managing Director of Morepen Laboratories Limited since October 2000. He has been Chairman of Morepen Laboratories Limited since October 2000 and has been its Director...

리더십 팀

이름위치테뉴어보상소유권
Sushil Suri
Chairman & MD24.1yrs₹39.11m1.22%
₹ 496.2m
Sanjay Suri
Whole-Time Director9.8yrs₹21.80m1.01%
₹ 408.4m
Ajay Sharma
Chief Financial Officer10.3yrs₹9.80m데이터 없음
Bhola Prasad
General Manager of Process Engineering & Technology Transferno data데이터 없음데이터 없음
Sunita Suri
Manager of Administrationno data데이터 없음0.58%
₹ 236.3m
Vipul Srivastava
Company Secretary & Compliance Officer6yrs₹1.84m데이터 없음
Vikas Sharma
Functional Head of Talent Acquisition & HRBPless than a year데이터 없음데이터 없음
Amita Sharma
Chief Operating Officer of APIless than a year데이터 없음데이터 없음
Anubhav Suri
Head of Medipath Divisionno data데이터 없음0.42%
₹ 168.9m
Kushal Suri
Head of International Business Developmentno data데이터 없음데이터 없음
Varun Suri
Chief Executive Officer of Consumer Divisionno data데이터 없음0.56%
₹ 225.9m
H. Manjunath
Chief of R&Dno data데이터 없음데이터 없음

7.9yrs

평균 재임 기간

47.5yo

평균 연령

경험이 풍부한 관리: MOREPENLAB 의 관리팀은 노련하고 경험 (평균 재직 기간 7.9 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Sushil Suri
Chairman & MD32.8yrs₹39.11m1.22%
₹ 496.2m
Sanjay Suri
Whole-Time Director5.3yrs₹21.80m1.01%
₹ 408.4m
Sharad Jain
Independent Directorless than a year데이터 없음데이터 없음
Praveen Dutt
Independent Director5.3yrs₹520.00k데이터 없음
- Savita
Independent Director4.4yrs₹300.00k데이터 없음
Ranjit Khattar
Independent Directorless than a year데이터 없음데이터 없음

4.8yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 이사회: MOREPENLAB 의 이사회는 경험(평균 재직 기간 4.8 년)으로 간주됩니다.